Related Experiment Videos
Furosemide use and hospitalization for benign prostatic hyperplasia
J A C Delaney1, L E Lévesque, M Etminan
1Division of Clinical Epidemiology, Royal Victoria Hospital and the Department of Epidemiology and Biostatistics, McGill University Health Center, Montreal, Canada. samy.suissa@clinepi.mcgill.ca
Summary
Furosemide use was associated with a reduced risk of hospitalization for prostatism, a marker of benign prostatic hyperplasia. This suggests a potential protective effect of furosemide in managing this condition.
Area of Science:
- Urology
- Pharmacology
- Epidemiology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in older men.
- Prostatism is a clinical manifestation of BPH requiring hospitalization.
- Furosemide, a loop diuretic, has demonstrated anti-inflammatory properties in prior research.
Purpose of the Study:
- To investigate the potential of furosemide in reducing the risk of hospitalization for prostatism.
- To explore the association between furosemide exposure and benign prostatic hyperplasia outcomes.
Main Methods:
- A case-control study was conducted using health insurance databases in Québec, Canada.
- The cohort comprised men aged 65 and older, with cases hospitalized for prostatism (ICD-9 code 600) and controls matched for follow-up.
- Exposure to furosemide and other diuretics was assessed in the 180 to 900 days preceding hospitalization, with logistic regression used for analysis.
Main Results:
- The study included 8,814 subjects (231 cases, 8,583 controls).
- Furosemide users showed a significantly lower rate of hospitalization for prostatism (adjusted rate ratio 0.49; 95% CI: 0.25-0.95).
- No association was found with thiazide or potassium-sparing diuretics; however, corticosteroid use suggested a protective effect (adjusted rate ratio 0.64; 95% CI: 0.44-0.93).
Conclusions:
- The findings support the hypothesis that furosemide may reduce the risk of hospitalization for prostatism.
- Furosemide could be a potential therapeutic agent for managing benign prostatic hyperplasia complications.
- Further research is warranted to confirm the anti-inflammatory role of furosemide in BPH.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...